Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A study on lung cancer provides additional proof of the value of screening.

2.

Enzalutamide vs Abiraterone: Which is Better for mCSPC?

3.

Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer

4.

Germline Profiling May Improve Risk Stratification in t-MNs

5.

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot